Stoke Therapeutics (STOK) Research & Development (2022 - 2025)
Historic Research & Development for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to $37.7 million.
- Stoke Therapeutics' Research & Development rose 6976.36% to $37.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.6 million, marking a year-over-year increase of 3676.32%. This contributed to the annual value of $89.1 million for FY2024, which is 839.34% up from last year.
- Per Stoke Therapeutics' latest filing, its Research & Development stood at $37.7 million for Q3 2025, which was up 6976.36% from $25.9 million recorded in Q2 2025.
- Stoke Therapeutics' 5-year Research & Development high stood at $37.7 million for Q3 2025, and its period low was $18.3 million during Q1 2022.
- Its 4-year average for Research & Development is $23.0 million, with a median of $21.1 million in 2024.
- As far as peak fluctuations go, Stoke Therapeutics' Research & Development soared by 80.56% in 2023, and later soared by 6976.36% in 2025.
- Over the past 4 years, Stoke Therapeutics' Research & Development (Quarter) stood at $21.1 million in 2022, then rose by 3.41% to $21.8 million in 2023, then increased by 7.55% to $23.4 million in 2024, then surged by 60.94% to $37.7 million in 2025.
- Its Research & Development was $37.7 million in Q3 2025, compared to $25.9 million in Q2 2025 and $32.7 million in Q1 2025.